Lenvatinib mesylate is a methanesulfonate salt of lenvatinib, a multi-kinase inhibitor. It is a pharmaceutical raw material used in the manufacturing of medications for cancer research and development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing LENVATINIB MESYLATE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Lincomycin hydrochloride
pharmaceutical raw material
Amodiaquine
pharmaceutical raw material
Dimethisoquin
pharmaceutical raw material
Gadopentetate dimeglumine
pharmaceutical raw material
The international HS code for LENVATINIB MESYLATE (CAS 857890-39-2) is 2933.49.
2933.49
2933 49 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide;methanesulfonic acid
HWLFIUUAYLEFCT-UHFFFAOYSA-N
COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl.CS(=O)(=O)O
Sourcing LENVATINIB MESYLATE?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.